Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
One-Month Dosing of Lemborexant for Treatment of Moderate OSA Patients With Low Arousal Threshold
NCT07683442Phase 2Not yet recruiting
- Sponsor
- Chulalongkorn University
- Start
- Sep 2026
- Primary completion
- Jun 2028
- Countries
- 1
01
Overview
A Phase 2 trial of lemborexant in obstructive sleep apnea (OSA), sponsored by Chulalongkorn University. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
lemborexant
03
Conditions
obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT07683442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07683442.